共 21 条
[1]
[Anonymous], [No title captured]
[9]
CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
[J].
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
2012, 97 (02)
:219-226